title: A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer.
authors.affiliation: Lilly USA, LLC, Indianapolis, IN 46285, USA. treatjo@lilly.com
authors.forename: Joseph
authors.initials: J
authors.lastname: Treat
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Edelman
authors.forename: Chandra P
authors.initials: CP
authors.lastname: Belani
authors.forename: Mark A
authors.initials: MA
authors.lastname: Socinski
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Monberg
authors.forename: Ruqin
authors.initials: R
authors.lastname: Chen
authors.forename: Coleman K
authors.initials: CK
authors.lastname: Obasaju